Fertilizer Canada releases 2020-2025 Strategic Plan

Fertilizer Canada’s Board of Directors recently approved the 2020-2025 Strategic Plan, which is the result of a widespread consulting process that included meetings with the Board of Directors, the Strategic Planning Steering Committee, Issue Committees, and staff meetings. It sets a new strategic direction for Fertilizer Canada for the coming five years, with a focus on delivering exceptional member value.

 

Fertilizer Canada is ready to meet the challenges in the future. We are well positioned to support our members through 2025, to advance the safe, secure, and sustainable production and use of fertilizer, through proactive science-based programs, innovation and advocacy. Members will continue to be our central focus as we build out our ‘Pillars of Success’ in Stewardship, Policy and Regulatory Affairs, Advocacy and Communications, and Organizational Excellence.

 

We look forward to working with our members and committees to deliver our strategic objectives over the course of the next 5 years.

 

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.